Literature DB >> 27370146

Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.

Tze Yee Lim1, Rajat J Kudchadker2, Jihong Wang2, R Jason Stafford3, Christopher MacLellan4, Arvind Rao5, Geoffrey S Ibbott2, Steven J Frank6.   

Abstract

PURPOSE: For postimplant dosimetric assessment, computed tomography (CT) is commonly used to identify prostate brachytherapy seeds, at the expense of accurate anatomical contouring. Magnetic resonance imaging (MRI) is superior to CT for anatomical delineation, but identification of the negative-contrast seeds is challenging. Positive-contrast MRI markers were proposed to replace spacers to assist seed localization on MRI images. Visualization of these markers under varying scan parameters was investigated.
METHODS: To simulate a clinical scenario, a prostate phantom was implanted with 66 markers and 86 seeds, and imaged on a 3.0T MRI scanner using a 3D fast radiofrequency-spoiled gradient recalled echo acquisition with various combinations of scan parameters. Scan parameters, including flip angle, number of excitations, bandwidth, field-of-view, slice thickness, and encoding steps were systematically varied to study their effects on signal, noise, scan time, image resolution, and artifacts.
RESULTS: The effects of pulse sequence parameter selection on the marker signal strength and image noise were characterized. The authors also examined the tradeoff between signal-to-noise ratio, scan time, and image artifacts, such as the wraparound artifact, susceptibility artifact, chemical shift artifact, and partial volume averaging artifact. Given reasonable scan time and managable artifacts, the authors recommended scan parameter combinations that can provide robust visualization of the MRI markers.
CONCLUSIONS: The recommended MRI pulse sequence protocol allows for consistent visualization of the markers to assist seed localization, potentially enabling MRI-only prostate postimplant dosimetry.

Mesh:

Year:  2016        PMID: 27370146      PMCID: PMC5438242          DOI: 10.1118/1.4953635

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  23 in total

1.  Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.

Authors:  Steven J Frank; Ramesh C Tailor; Rajat J Kudchadker; Karen S Martirosyan; R Jason Stafford; Andrew M Elliott; David A Swanson; David Sing; Jonathan Choi; Firas Mourtada; Geoffrey S Ibbott
Journal:  Med Dosim       Date:  2010-05-26       Impact factor: 1.482

2.  Defining a magnetic resonance scan sequence for permanent seed prostate brachytherapy postimplant assessment.

Authors:  David Bowes; Juanita M Crook; Rasika Rajapakshe; Cynthia Araujo; Brent Parker
Journal:  Brachytherapy       Date:  2012-04-17       Impact factor: 2.362

3.  Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy.

Authors:  Christopher S Melhus; Justin K Mikell; Steven J Frank; Firas Mourtada; Mark J Rivard
Journal:  Brachytherapy       Date:  2013-10-16       Impact factor: 2.362

4.  Localization of brachytherapy seeds in MRI by deconvolution.

Authors:  Ying Dong; Zheng Chang; Gregory Whitehead; Jim Ji
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

5.  Positive visualization of implanted devices with susceptibility gradient mapping using the original resolution.

Authors:  Gopal Varma; Rachel E Clough; Peter Acher; Julien Sénégas; Hannes Dahnke; Stephen F Keevil; Tobias Schaeffter
Journal:  Magn Reson Med       Date:  2010-12-16       Impact factor: 4.668

6.  Positive contrast MRI of prostate brachytherapy seeds by susceptibility mapping.

Authors:  Ying Dong; Jim Ji
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012

7.  Center-out radial sampling with off-resonant reconstruction for efficient and accurate localization of punctate and elongated paramagnetic structures.

Authors:  H de Leeuw; P R Seevinck; C J G Bakker
Journal:  Magn Reson Med       Date:  2012-07-30       Impact factor: 4.668

8.  MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy.

Authors:  Tze Yee Lim; R Jason Stafford; Rajat J Kudchadker; Madhuri Sankaranarayanapillai; Geoffrey Ibbott; Arvind Rao; Karen S Martirosyan; Steven J Frank
Journal:  Phys Med Biol       Date:  2014-04-28       Impact factor: 3.609

9.  A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.

Authors:  Steven J Frank; Mary J Johansen; Karen S Martirosyan; Mihai Gagea; Carolyn S Van Pelt; Agatha Borne; Yudith Carmazzi; Timothy Madden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-22       Impact factor: 7.038

10.  A novel MRI marker for prostate brachytherapy.

Authors:  Steven J Frank; R Jason Stafford; James A Bankson; Chun Li; David A Swanson; Rajat J Kudchadker; Karen S Martirosyan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

View more
  6 in total

1.  Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Authors:  Geoffrey V Martin; Thomas J Pugh; Usama Mahmood; Rajat J Kudchadker; Jihong Wang; Teresa L Bruno; Tharakeswara Bathala; Pierre Blanchard; Steven J Frank
Journal:  Brachytherapy       Date:  2017-05-10       Impact factor: 2.362

2.  Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.

Authors:  Jingfei Ma; Marinus A Moerland; Aradhana M Venkatesan; Tharakeswara K Bathala; Rajat J Kudchadker; Kristy K Brock; Steven J Frank
Journal:  Brachytherapy       Date:  2017-01-04       Impact factor: 2.362

3.  Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.

Authors:  Matteo Maspero; Peter R Seevinck; Nicole J W Willems; Gonda G Sikkes; Geja J de Kogel; Hans C J de Boer; Jochem R N van der Voort van Zyp; Cornelis A T van den Berg
Journal:  Radiat Oncol       Date:  2018-06-05       Impact factor: 3.481

4.  Quantitative analysis of image quality for acceptance and commissioning of an MRI simulator with a semiautomatic method.

Authors:  Xinyuan Chen; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2018-03-24       Impact factor: 2.102

5.  Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study.

Authors:  Jeremiah W Sanders; Aradhana M Venkatesan; Chad A Levitt; Tharakeswara Bathala; Rajat J Kudchadker; Chad Tang; Teresa L Bruno; Christine Starks; Edwin Santiago; Michelle Wells; Carl P Weaver; Jingfei Ma; Steven J Frank
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-24       Impact factor: 7.038

6.  Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.

Authors:  Tze Yee Lim; Rajat J Kudchadker; Jihong Wang; Tharakeswara Bathala; Janio Szklaruk; Thomas J Pugh; Usama Mahmood; Geoffrey S Ibbott; Steven J Frank
Journal:  J Contemp Brachytherapy       Date:  2016-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.